Psychotic Disorders: all 1,655 studies

Page 11 of 17. Open to participants first (298), then studies with results posted, then the rest; newest registration first within each.

• Effectiveness of a Mindfulness-based Group Training Addressing Social Cognition in First Episode Psychosis (AGES-Mind)CompletedNCT03309475Not applicable
• Using Mobile Technology to Enhance Early Psychosis Treatment DeliveryCompletedNCT03303456Not applicable
• Metacognitive Therapy and Work Interventions for Patients on Sick Leave Due to Common Mental DisordersStatus unknownNCT03301922Not applicable
• Brief Evidence-based Psychological Treatments for Emotional DisordersCompletedNCT03286881Not applicable
• Smartphone Applications Youth With Early Psychosis in Community Outpatient SettingsCompletedNCT03286595Not applicable
• Implementation of National Guidelines for Treatment of PsychosesCompletedNCT03271242
• A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic DisordersTerminatedNCT03261817Not applicable
• Cognitive Behavioral Social Skills Training in Early Onset PsychosisCompletedNCT03261557Not applicable
• Phenomics and Genomics of Clozapine PharmacotherapyStatus unknownNCT03253367
• Guided Dose Reduction of Antipsychotic in Patients With Psychosis in Remitted StatesStatus unknownNCT03248180
• Joint Crisis Plans or Crisis Cards for People With Severe Mental Disorders to Reduce Coercion in Psychiatric Care.Status unknownNCT03240380Not applicable
• Copeptin in Outcome Prediction of an Acute Psychotic EpisodeCompletedNCT03235908
• Influence of Amphetamine-induced Sensitization on Dopamine Synthesis and ReleaseStatus unknownNCT03223844Not applicable
• Cognitive Behavioural Therapy- Social Functioning In Adolescence With Recent Onset SchizophreniaCompletedNCT03217955Not applicable
• Psychosocial Intervention to Reduce Self-stigma and Improve Quality of Life Among People With Mental Illness in ChileCompletedNCT03197168Not applicable
• Early Intervention Psychosis Communication and Engagement TrialStatus unknownNCT03196128Not applicable
• IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2Active, not recruitingNCT03194815Phase 2
• Financial Incentives to Improve Acceptance of Antipsychotic InjectionsStatus unknownNCT03192631Not applicable
• Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)CompletedNCT03183609Not applicable
• Person-Centered Psychosis Care: An Educational InterventionCompletedNCT03182283Not applicable
• Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in SchizophreniaCompletedNCT03179696Not applicable
• The Evaluation of the Use of a New Physical Health PlanCompletedNCT03178279Not applicable
• The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum DisordersCompletedNCT03166098
• Psychoeducative Treatment of FEP With Mobile Training. ThinkAppCompletedNCT03161249Not applicable
• The Feasibility of a Novel Intervention for At Risk Mental StateStatus unknownNCT03160092Not applicable
• The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) StudyTerminatedNCT03152292
• Mindfulness Group-based Intervention for Early PsychosisCompletedNCT03143907Not applicable
• Video Games Among People With SchizophreniaCompletedNCT03133143Not applicable
• Cognitive AppRoaches to coMbatting SuicidalityCompletedNCT03114917Not applicable
• Reducing the Duration of Untreated PsychosisCompletedNCT03102151
• Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-upStatus unknownNCT03090503Phase 4
• 10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis IndividualsStatus unknownNCT03090490Not applicable
• Neural Biomarkers of Clozapine ResponseCompletedNCT03076346
• Efficacy of Transcranial Direct Current Stimulation in Treatment of Cognitive Deficits in Early Stages of PsychosisStatus unknownNCT03071484Not applicable
• rTMS Treatment for Cannabis Use Disorders in PsychosisTerminatedNCT03069612Not applicable
• Clonazepam Effects on Brain Oscillations and Cognition in SchizophreniaWithdrawnNCT03061136Phase 4
• Mobile Enhancement of Motivation in SchizophreniaCompletedNCT03059771Not applicable
• Testing a New Device to Advance the Use of Social Skills Training With Mental Health Consumers and CliniciansCompletedNCT03053557Not applicable
• The Appeal and Impact of E-cigarettes in Smokers With SMICompletedNCT03050853Not applicable
• Is Cognitive Training Neuroprotective in Early Psychosis?CompletedNCT03049800
• Raloxifene Augmentation in Patients With a Schizophrenia Spectrum DisorderCompletedNCT03043820Phase 3
• A Comparison of Cognitive Training Approaches in Psychotic DisordersCompletedNCT03024203Not applicable
• Return to Work Among Patients With Stress Related Mental Disorders - An Intervention in the Swedish Primary CareCompletedNCT03022760Not applicable
• Comparing Thinking Skills for Work (TSW)Home Practice Program With Traditional TSW ProgramCompletedNCT03005574Not applicable
• Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic DrugsStatus unknownNCT02986490Not applicable
• Berberine as Adjuvant Treatment for Schizophrenia PatientsCompletedNCT02983188Phase 2/3
• Clinical Trial of AVL-3288 in Schizophrenia PatientsCompletedNCT02978599Phase 1
• The Impact of a Helplessness and Recovery of an Empowerment Intervention on People Diagnosed With Schizophrenia: Findings From a Randomized Controlled TrialCompletedNCT02968667Phase 2
• tDCS Coupled With Virtual Rehabilitation for Negative Symptoms in At-Risk YouthStatus unknownNCT02951208Not applicable
• RCT Examining the Effectiveness of Digital Picture Frame Use in Inpatient SettingCompletedNCT02950571Not applicable
• Prednisolone Addition for Patients With Recent-onset Psychotic DisorderTerminatedNCT02949232Phase 4
• Psychosocial Intervention Designed to Familial Reintegration of Homeless With Mental Disorder in Maputo and Matola CityCompletedNCT02936141Not applicable
• CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty CareCompletedNCT02933567Not applicable
• Low Pulse Amplitude Seizure Therapy (LAP-ST Study)CompletedNCT02928159Phase 1
• Schizophrenia and the Gut MicrobiomeCompletedNCT02921243
• Cost-effectiveness of Interventions in First-episode PsychosisStatus unknownNCT02916303
• The Role of Nitric Oxide in Cognition in SchizophreniaCompletedNCT02906553Not applicable
• Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective DisorderCompletedNCT02901587Phase 1
• Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia PatientsCompletedNCT02897167
• COllaborative Shared Care to IMprove Psychosis OutcomeCompletedNCT02895269Not applicable
• Impact of Case-management on Therapeutic Alliance With First Episode Psychosis Patients (CAMAT)Status unknownNCT02873884
• Impact of Aerobic Exercise on Metabolic Syndrome, Neurocognition and Empowerment in Individuals With Mental DisordersStatus unknownNCT02858102Not applicable
• A Study of an Cognitive Behaviour Therapy for Internalised Stigma Intervention for Inpatients With PsychosisStatus unknownNCT02853396Not applicable
• Irish Omega-3 StudyStatus unknownNCT02848469Phase 2
• Reducing Duration of Untreated Psychosis Through Rapid Identification and EngagementTerminatedNCT02841956Not applicable
• Enhancing Cognitive Training Through Exercise Following a First Schizophrenia EpisodeCompletedNCT02823041Not applicable
• Striatal Connectivity and Clinical Outcome in PsychosisCompletedNCT02822092
• Texting for Relapse PreventionCompletedNCT02819349Not applicable
• Topiramate and Schizophrenia: Effects on Weight and PsychopathologyActive, not recruitingNCT02808533Not applicable
• Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional PsychosesCompletedNCT02807688Not applicable
• Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for PsychosisCompletedNCT02787135Not applicable
• Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With SchizophreniaCompletedNCT02787122Not applicable
• Cognitive Therapy for Distressing Visual Hallucinations: A Pilot StudyCompletedNCT02782507
• Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)CompletedNCT02782442Not applicable
• Expanded Access of Pimavanserin for Patients With PD PsychosisApproved for marketingNCT02762591
• The Staged Treatment in Early Psychosis StudyCompletedNCT02751632Phase 3
• Efficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize...CompletedNCT02748486Not applicable
• Adolescent Mental Health: Canadian Psychiatric Risk and Outcome StudyCompletedNCT02739932
• Compassion Focused Therapy for Distressing ExperiencesCompletedNCT02733575Not applicable
• Participatory Messaging in the UCLA Psychiatry Partial Hospitalization and Intensive Outpatient ProgramsCompletedNCT02708940Not applicable
• Microbiome and the Gut-Brain AxisCompletedNCT02693327
• Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on AdherenceStatus unknownNCT02665611Not applicable
• Video as a Tool to Improve Insight in SchizophreniaCompletedNCT02664129Not applicable
• Transcranial Direct Current Stimulation for Hallucinations in First-Episode SchizophreniaWithdrawnNCT02661347Not applicable
• Cbt for Psychosis and Affect on Psychosis SymptomsCompletedNCT02653729Phase 2
• Motivational Intervention for Physical Activity in PsychosisCompletedNCT02648321Not applicable
• Switching Antipsychotics: Abrupt Discontinuation Versus OverlapCompletedNCT02640300Phase 4
• A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective DisorderCompletedNCT02636842Phase 1
• Understanding and Helping Families: Parents With PsychosisStatus unknownNCT02622048Not applicable
• Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in EuropeCompletedNCT02597439Phase 4
• Positive Emotions Program for Schizophrenia (PEPS)CompletedNCT02593058Not applicable
• Brain Effects of Memory Training in Early PsychosisTerminatedNCT02584114Not applicable
• Antipsychotics and Risk of Hyperglycemic EmergenciesCompletedNCT02582736
• Modified Psychodynamic Psychotherapy for Patients With SchizophreniaCompletedNCT02576613Not applicable
• Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With AntipsychoticsCompletedNCT02573168Not applicable
• Evaluation of an Intervention to Promote Physical Activity in Outpatients With Mental DisordersCompletedNCT02569619Phase 2
• Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental StatesCompletedNCT02569307Phase 2
• Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581CompletedNCT02567370Phase 1
• Adult Study Oxytocin - BehavioralCompletedNCT02567032Early Phase 1
• Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase PsychosisCompletedNCT02566057Not applicable

← Psychotic Disorders overview